Anna Czarnota

Gdansk, PM 80307, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus.

Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus.

Journal: Scientific reports

Published: July 30, 2024

Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles.

Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles.

Journal: Microbiology spectrum

Published: January 31, 2023

Chimeric virus-like particles presenting tumour-associated MUC1 epitope result in high titers of specific IgG antibodies in the presence of squalene oil-in-water adjuvant: towards safe cancer immunotherapy.

Chimeric virus-like particles presenting tumour-associated MUC1 epitope result in high titers of specific IgG antibodies in the presence of squalene oil-in-water adjuvant: towards safe cancer immunotherapy.

Journal: Journal of nanobiotechnology

Published: December 09, 2021

Immunization with Leishmania tarentolae-derived norovirus virus-like particles elicits high humoral response and stimulates the production of neutralizing antibodies.

Immunization with Leishmania tarentolae-derived norovirus virus-like particles elicits high humoral response and stimulates the production of neutralizing antibodies.

Journal: Microbial cell factories

Published: July 07, 2021

Immune response against SARS-CoV-2 variants: the role of neutralization assays.

Immune response against SARS-CoV-2 variants: the role of neutralization assays.

Journal: NPJ vaccines

Published: May 19, 2021

Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.

Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.

Journal: Vaccines

Published: April 23, 2020

A Recombinant Turkey Herpesvirus Expressing F and HN Genes of Avian Avulavirus-1 (AAvV-1) Genotype VI Confers Cross-Protection against Challenge with Virulent AAvV-1 Genotypes IV and VII in Chickens.

A Recombinant Turkey Herpesvirus Expressing F and HN Genes of Avian Avulavirus-1 (AAvV-1) Genotype VI Confers Cross-Protection against Challenge with Virulent AAvV-1 Genotypes IV and VII in Chickens.

Journal: Viruses

Published: May 25, 2019

Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.

Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.

Journal: Scientific reports

Published: April 01, 2016

Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

Journal: Microbial cell factories

Published: October 10, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026